Search clinical trials for: human epidermal growth factor 2 negative (HER2-)
Total 104561 results
-
MIPO ClinicCompletedNonsmall-cell Lung CancerKazakhstan
-
Clinical Exercise Physiology and Rehabilitation...KAT General HospitalCompletedAnterior Cruciate Ligament RuptureGreece
-
Cairo UniversityUnknown
-
Xijing HospitalNot yet recruitingBreast Cancer | HER2-positive Breast Cancer
-
Shengjing HospitalRecruiting
-
DualityBio Inc.BioNTech SERecruitingMetastatic Breast CancerUnited States, China, Australia
-
SangathHarvard Medical School (HMS and HSDM); London School of Hygiene and Tropical...CompletedMental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)India
-
AstraZenecaDaiichi SankyoCompletedBreast CancerDenmark, Finland, Italy, Norway, Spain, Sweden, Poland, United States, Canada, Germany, Japan, Netherlands, Portugal, Switzerland, Australia, United Kingdom, Belgium, Ireland
-
Instituto do Cancer do Estado de São PauloWithdrawnBreast Cancer | HER-2 Positive Breast CancerBrazil
-
Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo CompanyAstraZenecaCompletedNeoplasm, Breast | Adenocarcinoma, GastricTaiwan
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
Institut Claudius RegaudTerminated
-
Sun Yat-sen UniversityRecruiting
-
Zagazig UniversityUnknownSecond Trimester AbortionEgypt
-
Akdeniz UniversityRecruiting
-
Dana-Farber Cancer InstituteGenentech, Inc.; Eisai Inc.TerminatedMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Libbs Farmacêutica LTDAActive, not recruitingBreast CancerBrazil
-
Davidzon, Guido, M.D.Weston Havens FoundationRecruiting
-
Zhi YangWithdrawnGlioma | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung CancerChina
-
iOMEDICO AGNovartis Pharmaceuticals; Arbeitsgemeinschaft fur Internistische OnkologieCompletedBreast Cancer Recurrent | HER2/Neu-negative Carcinoma of Breast | Hormone Receptor Positive Malignant Neoplasm of BreastGermany
-
Boehringer IngelheimCompleted
-
Veana TherapeuticsUniversity of WashingtonRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | HER2 Positive Breast Carcinoma | Metastatic Breast Carcinoma | Refractory Breast CarcinomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingBreast NeoplasmsKorea, Republic of, Germany, United States, United Kingdom, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Greece, Guatemala, Hungary, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Phili... and more
-
Johannes Gutenberg University MainzPierre Fabre Pharma GmbHCompleted
-
German Breast GroupBoehringer IngelheimCompleted
-
Merrimack PharmaceuticalsTerminatedBreast Cancer | HER2 Positive Breast CancerSpain, United States, Italy, France, Canada, Belgium, Austria, Germany, Czech Republic
-
Dompé Farmaceutici S.p.APRA Health SciencesCompletedMetastatic Breast CancerUnited States
-
Nantes University HospitalTerminatedRelapsed/Refractory LeukemiaFrance
-
Eisai Inc.Halozyme TherapeuticsTerminated
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingHormone Receptor Positive HER-2 Negative Breast CancerGermany
-
Peking Union Medical College HospitalCompletedBreast CancerChina
-
Providence Health & ServicesActive, not recruitingBreast CancerUnited States
-
Huashan HospitalRecruitingHER2-positive Breast CancerChina
-
University of Massachusetts, WorcesterCompleted
-
Anhui Provincial HospitalUnknownHER2 Positive Breast Carcinoma
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone... and other conditionsUnited States
-
BayerRecruitingAdvanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationHong Kong, United States, Taiwan, Spain, Belgium, China, Japan, France, Korea, Republic of, Singapore, Poland, Israel, Italy, Netherlands, Portugal, Brazil
-
Hoffmann-La RocheCompleted
-
Karolinska University HospitalRecruitingBreast Cancer | Esophageal Neoplasms | HER2-positive Gastric Cancer | Gastric Neoplasms MalignantSweden
-
Novartis PharmaceuticalsCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheNorwegian Radium HospitalCompleted
-
Providence Health & ServicesMerck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Fudan UniversityGeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingAdvanced/ Metastatic Her-2 Positive Breast CancerChina
-
British Columbia Cancer AgencyGenomic Health®, Inc.Not yet recruiting